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Novelty and impact:  
Breast cancer is the most common cancer among women and prevention strategies 
are needed to reduce incidence worldwide. An a priori breast cancer-specific healthy 
lifestyle index score was generated to investigate the joint effect of modifiable 
lifestyle factors on postmenopausal breast cancer risk in a large European cohort. 
There was a 3% lower risk of breast cancer per point increase of the index score, 
supporting behaviour modification as an effective prevention strategy for breast 
cancer incidence. 
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ABSTRACT 
 
Breast cancer is the most common cancer among women and prevention strategies 
are needed to reduce incidence worldwide. A healthy lifestyle index score (HLIS) was 
generated to investigate the joint effect of modifiable lifestyle factors on 
postmenopausal breast cancer risk. The study included 242,918 postmenopausal 
women from the multinational European Prospective Investigation into Cancer and 
Nutrition (EPIC) cohort, with detailed information on diet and lifestyle assessed at 
baseline. The HLIS was constructed from five factors (diet, physical activity, smoking, 
alcohol consumption, and anthropometry) by assigning scores of 0 to 4 to categories 
of each component, for which higher values indicate healthier behaviours. Hazard 
ratios (HR) were estimated by Cox proportional regression models. During 10.9 years 
of median follow-up, 7,756 incident breast cancer cases were identified. There was a 
3% lower risk of breast cancer per point increase of the HLIS. Breast cancer risk was 
inversely associated with a high HLIS when fourth versus second (reference) 
categories were compared (adjusted HR = 0.74; 95% confidence interval (CI): 0.66, 
0.83). The fourth versus the second category of the HLIS was associated with a 
lower risk for hormone receptor double positive (adjusted HR = 0.81, 95% CI: 0.67, 
0.98) and hormone receptor double negative breast cancer (adjusted HR = 0.60, 
95% CI: 0.40, 0.90). Findings suggest having a high score on an index of combined 
healthy behaviours reduces the risk of developing breast cancer among 
postmenopausal women. Programmes which engage women in long term health 
behaviours should be supported. 
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INTRODUCTION 
Breast cancer is the most common cancer among women with an estimated 1.4 
million new cases diagnosed worldwide in 2008, almost one quarter of all female 
cancers. It is the most common cancer in both developed and developing regions; 
the highest reported incidence for breast cancer is in Western Europe, with a rate of 
approximately 90 cases per 100,000 women 1.   
A number of established risk factors for breast cancer have been identified, including 
age, reproductive history, hormone levels/use, family history of breast cancer, breast 
density, and adult attained height 2-6. In addition to these, individual modifiable 
lifestyle factors have been shown to be associated with breast cancer risk such as 
diet 7-10, physical activity 11,12, smoking 13,14, alcohol consumption 15,16, and body 
fatness 17,18. As people have a propensity to follow common behavioural patterns 19, 
and such lifestyle factors are often clustered, it seems prudent to investigate these 
lifestyle factors jointly.  
There is accumulating evidence associating combined lifestyle factors, or patterns of 
behaviour, to cardiovascular disease 19,20 and diabetes 21, and most recently, to 
cancer 22,23. The benefit of adhering to a healthy lifestyle has been quantified 
specifically in relation to breast cancer risk for Mexican women 24, where in a case-
control study an 80% lower risk was observed for postmenopausal women when 
comparing breast cancer risk in the highest to the lowest quintile of a healthy lifestyle 
index constructed by means of principal components.  
There is mounting literature on the relationship between nutrition and breast cancer. 
Several dietary components have reported associations that are supported by a 
biological plausibility 25 but for which current evidence is too limited to permit a 
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probable causal judgement in their aetiological role 11. Fibre 26,27, folate 28, 
carbohydrates 29,30, and different fatty acids 31-34 have all been posited to affect breast 
cancer risk, have all been reviewed 25,35,36, and all remain suggestive of a causal 
relationship 37. 
A recent study assessed the association between concordance with World Cancer 
Research Fund (WCRF) / American Institute for Cancer Research (AICR) overall 
cancer prevention guidelines and subsequent cancer risk, including breast cancer, in 
the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort and 
reported a protective effect of adhering to the guidelines 38. To further investigate 
breast cancer risk and lifestyle behaviours in the EPIC cohort, a breast cancer 
specific a priori health index was created based on posited dietary components, high 
physical activity, avoidance of smoking, no alcohol consumption, and low BMI as 
previously proposed 19,21,39, and then used to assess the association of a healthy 
lifestyle index with the risk of breast cancer in the study cohort.  
 
METHODS 
Study population 
EPIC is a large prospective cohort study across 23 centres in 10 European countries 
(Denmark, France, Germany, Greece, Italy, the Netherlands, Norway, Spain, 
Sweden, and the United Kingdom) 40. The cohort of 521,330 healthy men and women 
recruited from 1992 to 2000, and aged between 25 and 70 years, was primarily 
designed to investigate the link between nutrition, dietary habits and lifestyle, and 
cancer incidence. Participants were enrolled from the general population, within 
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defined geographical or administrative areas, with exceptions for France (national 
health insurance scheme members), Utrecht and Florence (breast cancer screening 
participants), Oxford (health conscious, mainly vegetarian, volunteers), and some 
centres from Italy and Spain (blood donor participants). The rationale for EPIC, study 
design, and methods have been described in detail elsewhere 40. The study obtained 
ethical approval from participating centres and IARC ethics committees. Informed 
consent was given by all study participants. 
Data collection and follow-up  
Validated country-specific questionnaires were completed by participants at baseline, 
including self-administered semi-quantitative food frequency questionnaires or 
interviewer-administered diet history questionnaires, and semi-quantitative food 
frequency questionnaires to measure usual intakes 41. In an ~8% random sub-
sample, standardized interviewer-administered 24-hour recalls were collected in a 
calibration study 42. Energy intake was estimated using the harmonized EPIC nutrient 
database 43. Sociodemographic information, physical activity, alcohol consumption, 
smoking, and medical and reproductive history were captured from lifestyle 
questionnaires, and anthropometric measurements taken at all centres (except 
Oxford and France, where they were self-reported) 40.  
Follow-up was done through cancer registries in Denmark, Italy, the Netherlands, 
Norway, Spain, Sweden, and the UK. For France, Germany, and Greece, follow-up 
was done via health insurance records, cancer/pathology registrations, and through 
participants and their next-of-kin. Follow-up began at date of enrolment and ended at 
date of cancer diagnosis, death, or last complete follow-up (December 2004 to June 
2010, depending on the centre), whichever came first. Breast cancer cases were 
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defined as first primary invasive breast tumours (coded C50.0 to 50.9 using the 10th 
Revision of International Statistical Classification of Diseases). Information on 
oestrogen receptor (ER) and progesterone receptor (PR) statuses was provided by 
each centre on the basis of pathology reports. 
The original EPIC cohort comprised 367,993 women; 334,848 after the exclusion of 
women with prevalent and recurring cancers or missing follow up information 
(23,053), missing dietary or lifestyle questionnaires (3,339), and those in the top or 
bottom 1% of the ratio of energy intake to energy requirement (6,753). Energy 
requirement is calculated as basal metabolic rate times the moderate physical activity 
level of 1.55. The current study was based on data from 242,918 postmenopausal 
women (premenopausal n = 37,236), following exclusions of women with in situ 
cases (1,349) and missing data for the components of the lifestyle index (53,345), 
including all women from Umea in Sweden, and Norway, where information on 
physical activity was not collected. 
Index construction 
Score for diet 
Intakes of seven dietary factors were combined for the diet score: cereal fibre, folate, 
the ratio of polyunsaturated to saturated fat, fatty fish (as a marker for omega-3 fatty 
acids), margarine (as a marker for industrially produced trans-fats), glycaemic load, 
and fruits and vegetables. Consumption of dietary components were grouped into 
country-specific deciles and scored from 0 to 9 (inverse for trans-fat and glycaemic 
load), with 0 being least healthy consumption. The individual scores were summed to 
a total diet score, and then categorised into quintiles. For one centre (Potsdam, 
Germany), which did not have food frequency data specifically for fatty fish, 
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consumption of total fish was weighted based on the fatty fish proportions of total fish 
reported in 24-hour recalls of the calibration study 42. 
Score for health index 
The overall health index was determined by assigning scores of 0 to 4 to each 
individual variable category, for which a higher point value indicates a healthier 
behaviour. The health index ranged from 0 to 20. Healthiest behaviour was defined 
as never smoking (never = 4, ex-smokers quit > 10 years = 3, ex-smokers quit <= 10-
years = 2, current <= 15 cigarettes/day = 1, current > 15 cigarettes/day = 0), no 
consumption of alcohol (none = 4, 0.1-4.9 (g/day) = 3, 5.0-9.9 (g/day) = 2, 10.0-19.9 
(g/day) = 1, > 20 (g/day) = 0), top quintile of physical activity based on recreational 
and household metabolic equivalent tasks (5th quintile = 4, 4th quintile = 3, 3rd 
quintile = 2, 2nd quintile = 1, 1st quintile = 0),  BMI in the bottom quintile (1st quintile 
= 4, 2nd quintile = 3, 3rd quintile = 2, 4th quintile = 1, 5th quintile = 0), and a healthy 
diet i.e., high in cereal fibre, folate, fatty fish, with a high ratio of polyunsaturated to 
saturated fat, high intake of fruits and vegetables, and low in margarine/trans-fat and 
glycaemic load (5th quintile = 4, 4th quintile = 3, 3rd quintile = 2, 2nd quintile = 1, 1st 
quintile = 0).  
Statistical analysis 
Menopausal status was provided at time of recruitment; women were considered as 
postmenopausal when they reported not having had any menses over the past 12 
months, or when they reported bilateral ovariectomy. Women with missing or 
incomplete questionnaire data, or with reported previous hysterectomy, were 
considered postmenopausal only if they were older than 55 years. Women were 
considered with unknown menopausal status when they were between 46 and 55 
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years of age, and had missing or incomplete questionnaire data, or reported previous 
hysterectomy (without ovariectomy). For these analyses, a cut-point of 50 years 
(median age of menopause within EPIC) was used for age of menopause among 
those women which were pre and perimenopausal at recruitment, and this was 
considered as point of entry into the study.  
Descriptive statistics are provided by cross tabulations with medians and inter-
quartile ranges for continuous variables, and percentages for categorical variables. 
Cox proportional hazard regression models were used to estimate associations 
between the healthy lifestyle index and breast cancer. Age was used as the primary 
time variable, with entry time defined as age at study entry, and exit time as age at 
diagnosis of breast cancer or censoring (which ever occurred first). 
Hazard ratios (HR) and 95% confidence intervals (CI) were stratified by centre, to 
control for centre-specific effects, and 1-year age bands (age at study entry). Models 
were adjusted by height (continuous), age at menarche (<12, 12-14, >14, unknown), 
age at full term pregnancy (nulliparous, <21, 21-30, >30, unknown), education 
(none/primary, secondary/technical, university, unknown), oral contraceptive (OC) 
use (never, ever, unknown), hormone replacement therapy (HRT) use (never, ever, 
unknown), breastfeeding (never, ever, unknown), total energy intake excluding 
alcohol (continuous). The healthy index was modelled as a continuous and 
categorical variable (≤5, 6-10, 11-15, ≥16), using the second lowest scoring group as 
the reference category. The test for trend was performed by assigning median values 
of each of the four categories of the index, which was then modelled as a continuous 
variable. Heterogeneity of association by BMI and HRT was assessed with 
interaction terms and associated log likelihood ratio tests; no evidence of interaction 
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was found.  Separate models were fitted according to the breast cancer hormone 
receptor status: ER positive and PR positive, and ER negative and PR negative 
tumours, while censoring other combinations of tumour hormone receptors.   
Two-sided p-values are provided with statistical significance set at p < 0.05. All 
analyses were performed using Stata version 11. 
 
RESULTS 
Among the total of 242,918 postmenopausal women, there were 7,756 first primary 
incident breast cancer cases recorded during a median follow-up time of 10.9 years 
and 2,343,075 accumulated person-years. The median age at start of follow-up was 
53.2 years. Table 1 shows the numbers of cohort participants, median ages at entry, 
frequencies of breast cancer cases, and follow-up years for each EPIC country in the 
study.  
Table 2 shows medians, or percentages, for each component of the healthy lifestyle 
index, and for each covariate characteristic. Across categories of the index score, 
total energy intake was slightly higher among the healthy behaviour groups. The 
percentage of women educated below secondary level increased among the healthy 
behaviour groups, as did the percentage of women who had ever breastfed. The 
frequency of OC and HRT use declined across the least healthy to most healthy 
behaviour categories of the index. 
Table 3 shows the scoring system used for the individual components of the healthy 
lifestyle index, and the corresponding hazard ratios (HR) and 95% confidence 
intervals (CI) for each component score and breast cancer, adjusted for the other 
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covariates. Healthy behaviours were inversely associated to breast cancer risk; 
although not all components and score levels reached statistical significance. 
Modelled as a continuous variable, there was a 3% lower risk (adjusted HR 0.97, 
95% CI: 0.96, 0.98) of breast cancer per point score of the index. Table 4 shows the 
crude and adjusted HRs and 95% CIs for the association between the healthy 
lifestyle index and breast cancer for all women, and by tumour hormone status. For 
all women, there was a 26% lower risk (adjusted HR 0.74, 95% CI: 0.66, 0.83) of 
breast cancer in the fourth category of the index (most healthy) compared to the 
second (reference) category of the index score. Women in the first category (least 
healthy) had a 19% greater risk of breast cancer compared to their counterparts in 
the second (reference) category of the index score (adjusted HR 1.19, 95% CI: 1.07, 
1.31). There was a lower risk for women with both hormone receptor double positive 
and double negative breast cancer, comparing the fourth category to the reference 
category of the index score (adjusted HR 0.81, 95% CI: 0.67, 0.98 and 0.60, 95% CI: 
0.40, 0.90, respectively). 
To investigate the possibility of confounding by family history of breast cancer, this 
was included, and models rerun for those centres that had family history available 
(42% of the women, n=102,579). There was no notable change in results from the 
ones presented here. 
To account for measurement errors in reporting food consumptions, the dietary 
components were additionally rescaled by country-specific differences between food 
frequency and 24-hour recall means. To account for possible misclassification due to 
high-energy intakes, models were run based on the residuals from the regression of 
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dietary components on total energy intake. These results (not shown) were not 
notably different from the uncorrected models reported.  
Sensitivity analyses were performed to assess the robustness of the findings. Models 
were run separately for Northern, Central, and Southern European based centres 
and no material difference in results (not shown) were observed. Reverse causality 
was tested through the exclusion of women whose breast cancer diagnosis was 
within their first 2 years of follow up; these results (not shown) did not differ from 
those of the entire cohort. Further analyses were performed with the exclusion of 
women with a BMI of less than 18.5 kg/m2, and with the exclusion of energy intake 
under-reporters, using the Goldberg cut-off for physical activity level 1.14 44. Finally, 
the analyses were rerun with the exclusion of former drinkers from the non-drinker 
category. None of the sensitivity analyses materially altered results or changed 
interpretation of findings. 
 
DISCUSSION 
This study based on a large prospective cohort has found a lower risk of breast 
cancer in postmenopausal women with healthier lifestyles. Findings suggest that 
modification of behaviour resulting in a one point increase in the healthy lifestyle 
index score correspond to a 3% lower breast cancer risk.  
All individual components of the healthy lifestyle index were significantly associated 
with breast cancer risk, except for the smoking component, which did not reach 
conventional significance. Smoking, while the biggest risk factor for cancer overall, is 
not an established risk factor for breast cancer. Although this exposure is frequently 
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debated, smoking has been found to be positively associated with breast cancer in 
populations with high smoking prevalence 14, or long durations 45,46. The fact that not 
all components are equally related to breast cancer risk implies that a factor which is 
less strongly related dilutes out the effect of another one which is more strongly 
related. However, the combined healthy lifestyle index was overall more strongly 
associated with breast cancer risk as compared to the individual components of the 
index.  
For the healthy lifestyle index, BMI was used as a measure for overall body fatness. 
However, as there is evidence to suggest that central adiposity may be a better 
predictor of postmenopausal breast cancer 47, various anthropometric measures 
were included in additional analyses. The use of waist circumference, waist to hip 
ratio, or waist to height ratio as a component in place of BMI did not materially alter 
our results. Therefore BMI was used in the index for reasons of data completeness. 
Findings for the current study are consistent with two previous studies, which found 
protective associations between breast cancer and healthy lifestyle indexes. A 
relatively small Mexican case-control study found that women in the highest quintile 
of the a posteriori calculated healthy lifestyle index had significantly lower odds of 
developing breast cancer than their counterparts in the lowest quintile of the index 
(premenopausal OR 0.50, 95% CI 0.29 to 0.84; postmenopausal OR 0.20, 95% CI 
0.11 to 0.37) 24. Their index considered healthy behaviour as being in the lowest 
tertile of the Western dietary pattern, never consuming alcohol, smoking less than 
100 cigarettes, and practicing moderate and vigorous intensity exercise 24. More 
recently, a study based on the EPIC cohort found a lower breast cancer risk for 
women in their highest scoring category of a score based on adherence to 
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WCRF/AICR recommendations 11 compared to their lowest category (HR 0.84, 95% 
CI 0.78 to 0.90) 38. The components of this index for all cancer were: body fatness, 
physical activity, foods that promote weight gain, plant foods, red and processed 
meat, alcohol intake, and breastfeeding 38. The breast cancer specific health index 
used for the current study resulted in an even greater risk reduction, and the 
association between index and breast cancer risk was also able to be investigated 
according to hormone receptor status. 
The current study has several strengths, including the large size and prospective 
design of the cohort, tumour hormone receptor status, and the detailed dietary and 
lifestyle information. Nevertheless, consumption of fatty fish was used as a marker 
for omega3 fatty acids in the construction of the diet score, and information was not 
available for trans-fat in the dataset; therefore, margarine was used as an indicator 
because this food group has been described in the literature as the main source for 
industrially produced trans fatty acids 48. Margarine has been related to plasma 
elaidic acid (a biomarker for trans-fat intake) in EPIC showing the strongest 
correlation in men and women among several food groups examined 49. Lastly, to 
avoid high correlations within and between food groups, the number of indicator 
foods for an index should be restricted to as few as possible.  The highest correlation 
of dietary components in the current study was between folate and fruit and 
vegetables; nevertheless this was included as the authors specifically wanted to 
capture the importance of folate in relation to breast cancer. 
There was no specific information on dietary supplementation available, particularly 
for folate and omega3 supplementation. However, there was general information 
available, whether vitamin or mineral supplements were taken without stipulation of 
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what those supplements contained. Sensitivity analyses excluding women using 
unspecified supplements showed similar results. 
Although index components were equally weighted, there is likely to be unintentional 
weighting due to some factors being “recommended” items or those seen as positive 
like physical activity while others are “moderation” items or those perceived as 
negative like smoking. Recommended index components are behaviours which are 
encouraged behaviours, and as such, they may be unintentionally weighted through 
their promotion more than behaviours which are discouraged, such as the 
moderation index components 50. 
A further consideration in the interpretation of these results is that EPIC participants 
are volunteers, and as such this is not an ordinary population-based cohort. The 
cohort is more likely to be healthier than the general population, and therefore the 
estimates may be attenuated, providing an underestimation of the association 
between healthy lifestyle and breast cancer in Europe.  
In conclusion, we evaluated the association between a healthy lifestyle index 
(including healthy diet, moderate and vigorous-intensity physical activity, avoidance 
of smoking and alcohol consumption, and low BMI) and the risk of breast cancer 
among postmenopausal women, and found a protective association of a healthy 
lifestyle among all women. The combined healthy lifestyle index was overall more 
strongly associated with breast cancer risk as compared to the individual 
components. These findings suggest that breast cancer prevention policies should 
include strategies to engage all women in lasting healthy diet and lifestyle habits.  
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TABLES 
Table 1. Distribution of postmenopausal women and breast cancer cases by country in the 
European Prospective Investigation into Cancer and Nutrition cohort study, 1992–2000 
Country cohort age* cases follow-up person-years 
  (median)  (median)  
Denmark 28,038 56.2 1,241 11.6 309,699 
France 62,766 51.6 2,310 9.9 576,428 
Germany  21,567 52.5 601 8.3 170,890 
Greece 11,884 58.3 140 10.0 104,357 
Italy 27,999 51.8 779 10.5 256,685 
Netherlands 20,210 55.0 684 11.7 218,174 
Spain 21,719 50.0 332 10.5 196,607 
Sweden 13,800 56.6 637 13.7 178,101 
UK 34,935 52.9 1,032 10.8 332,134 
Total 242,918 53.2 7,756 10.9 2,343,075 
      
*age at beginning of follow-up       
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Table 2. Characteristics of postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study according 
to healthy lifestyle index category, 1992–2000  
Index component 1 (≤5 points) 2 (6-10 points) 3 (11-15 points) 4 (≥16 points) All 
diet score (units) 24 (21-29) 29 (24-34) 34 (29-39) 40 (23-43) 32 (26-37) 
alcohol (g/day) 20.3 (10.6-31.7) 8.5 (1.9-17.9) 2.3 (0.3-8.0) 0.4 (0-2.6) 4.2 (0.6-12.2) 
physical activity (METS/week) 41 (29-59) 62 (40-90) 99 (66-136) 140 (107-167) 82 (51-123) 
BMI (kg/m2) 27 (24-30) 25 (22-28) 24 (21-27) 22 (20-24) 25 (22-28) 
smoking (% ever) 96 70 34 12 49 
Covariate       
age at entry (years) 53 (50-58) 53 (50-59) 54 (50-60) 53 (50-60) 53 (50-59) 
height (cm) 162 (158-166) 162 (158-166) 161 (156-165) 161 (157-166) 161 (157-166) 
age at menarche (years) 13 (12-14) 13 (12-14) 13 (12-14) 13 (12-14) 13 (12-14) 
age at full term pregnancy (years) 24 (21-27) 24 (22-27) 25 (22-27) 25 (23-28) 24 (22-27) 
energy intake (kcal/day) 1752 (1437-2122) 1837 (1518-2212) 1875 (1557-2250) 1916 (1588-2304) 1858 (1538-2234) 
nulliparity (%) 5 3 2 3 3 
education (% below secondary) 28 28 35 35 32 
OC use (% ever) 62 59 52 47 55 
HRT use (% ever) 33 30 26 23 27 
breastfeeding (% ever) 64 67 70 72 69 
 
Values are medians (25th-75th percentiles) unless otherwise specified.
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Table 3. Associations for healthy lifestyle components and breast cancer risk among 
postmenopausal women in the European Prospective Investigation into Cancer and Nutrition 
cohort study, 1992–2000 
Index component score  HR 95% CI p-trend 
diet     
1st quintile (3 – 25) 0 1 reference 0.005 
2nd quintile (26 – 30) 1 0.93 0.87, 0.99  
3rd quintile (31 – 34) 2 0.98 0.91, 1.06  
4th quintile (35 – 39) 3 0.89 0.83, 0.95  
5th quintile (40 – 63) 4 0.90 0.84, 0.97  
BMI      
5th quintile (29 + ) 0 1 reference < 0.001 
4th quintile (26 – 29) 1 0.91 0.84, 0.98  
3rd quintile (24 – 26) 2 0.92 0.85, 0.99  
2nd quintile (22 – 24) 3 0.87 0.80, 0.93  
1st quintile (< 22) 4 0.81 0.74, 0.87  
Physical activity      
1st quintile (< 45 METs/week) 0 1 reference 0.001 
2nd quintile (45 – 69 METs/week) 1 0.97 0.91, 1.04  
3rd quintile (69 – 96 METs/week) 2 0.94 0.89, 1.02  
4th quintile (96 – 134 METs/week) 3 0.90 0.83, 0.97  
5th quintile (134 + METs/week) 4 0.87 0.80, 0.95  
alcohol     
> 20 (g/day) 0 1 reference < 0.001 
10.0-19.9 (g/day) 1 0.91 0.85, 0.98  
5.0-9.9 (g/day) 2 0.84 0.78, 0.91  
0.1-4.9 (g/day)  3 0.81 0.76, 0.87  
never 4 0.84 0.78,0.93  
smoking     
current > 15 cigarettes/day 0 1 reference 0.171 
current <= 15 cigarettes/day 1 0.87 0.79, 0.96  
ex-smokers quit <= 10-years 2 0.87 0.77, 0.99  
ex-smokers quit > 10 years 3 0.91 0.82, 1.02  
never 4 0.87 0.78, 0.96  
 
Stratified by study centre and age, and adjusted for height, age at menarche, age at first pregnancy, 
education, HRT, OC, breastfeeding, non-alcohol energy intake, and other index components. 
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Table 4. Associations for the healthy lifestyle index and breast cancer risk among postmenopausal women in the European Prospective Investigation into 
Cancer and Nutrition cohort study, 1992–2000 
  Categorical index score   
  1 (≤5 points) 2 (6-10 points) 3 (11-15 points) 4 (≥16 points) p trend 
Women   10,280  93,036  123,784  15,818   
Cases   451  3,287  3,656  362   
Unadjusted HR (95% CI)  1.18  (1.07, 1.30) 1  (reference) 0.91 (0.87, 0.95) 0.75 (0.67, 0.83)  < 0.001 
Adjusted HR (95% CI)  1.19  (1.07, 1.31) 1  (reference) 0.90 (0.86, 0.95) 0.74 (0.66, 0.83)  < 0.001 
Continuous Adjusted HR (95% CI) per unit score 0.97 (0.96, 0.98)      
          
ER+ and PR+  158  1,122  1,179  127   
Unadjusted HR (95% CI)  1.22  (1.03, 1.45) 1  (reference) 0.89 (0.82, 0.97) 0.82 (0.68, 0.99)   0.003 
Adjusted HR (95% CI)  1.23  (1.04, 1.45) 1  (reference) 0.89 (0.82, 0.97) 0.81 (0.67, 0.98)   0.002 
Continuous Adjusted HR (95% CI) per unit score 0.96 (0.95, 0.98)      
          
ER- and PR-  45  315  317  26   
Unadjusted HR (95% CI)  1.22  (0.89, 1.67) 1  (reference) 0.88 (0.75, 1.03) 0.61 (0.40, 0.91)  0.013 
Adjusted HR (95% CI)  1.23  (0.90, 1.69) 1  (reference) 0.87 (0.74, 1.02) 0.60 (0.40, 0.90)  0.009 
Continuous Adjusted HR (95% CI) per unit score 0.96 (0.94, 0.99)      
          
 
Stratified by study centre and age, and adjusted for height, age at menarche, age at first pregnancy, education, HRT, OC, breastfeeding, and non-alcohol energy intake. 
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Supplementary Table 1. Range for each dietary component of the diet score by overall decile of the European Prospective Investigation into Cancer and 
Nutrition cohort study, 1992–2000 
Decile Glycaemic Load Cereal Fibre Fatty Fish 
Fruits & 
Vegetables Folate PUFA:SFA ratio Margarine 
    (g) (g) (g) (g)   (g) 
 min max min max min max min max min max min max min max 
1 132.1 462.1 0 6.5 0 3.3 0 474.1 44.5 252.2 0.07 0.32 1.72 209.29 
2 117.5 202.5 2.0 8.0 0.1 5.5 150.7 562.9 157.8 291.3 0.24 0.39 0.56 52.21 
3 107.5 174.8 2.8 9.3 0.4 7.3 182.5 637.5 179.6 321.7 0.28 0.44 0.36 41.17 
4 99.7 157.3 3.5 10.5 0.7 9.0 208.4 703.8 197.4 350.3 0.31 0.49 0.13 35.15 
5 93.1 142.7 4.1 11.6 0.3 10.7 233.8 768.9 212.8 378.7 0.33 0.55 0.01 30.40 
6 86.5 130.1 4.8 13.2 1.4 12.7 262.3 838.8 227.5 411.0 0.36 0.60 0.09 26.41 
7 79.7 118.7 5.5 14.7 2.0 16.1 293.5 918.1 242.8 448.9 0.38 0.67 0.05 22.05 
8 72.6 107.4 6.3 16.2 2.9 21.9 331.4 1017.7 261.1 501.6 0.42 0.76 0.02 17.56 
9 62.9 95.8 7.4 19.3 4 49.3 382.4 1179.5 283.2 587.1 0.46 1.02 0.01 13.13 
10 7.9 84.4 8.9 65.4 6.2 748.7 460.9 5650.9 319.8 4332.3 0.53 3.71 0 6.73 
 
 
 
